According to Brown et al. [5], compound 6 (the 3,4-dimethoxy derivative) was expected to show the highest antitumour activity, where it was introduced in the aforementioned research as a promising protein kinase inhibitor for the treatment of type 2 diabetes mellitus T2DM. This evidence concerns the gene WEE1 and diabetes mellitus.